Integrating metabolomics and transcriptomics for probing Se anticancer mechanisms

Drug Metabolism Reviews

Volumn 38, Issue 4, 2006, Pages 707-732

  Fan, Teresa W M ^a   Higashi, Richard M ^b   Lane, Andrew N ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b NONE

Author keywords

13C isotopomer profiling; FT MS; GC tandem MS; Lung adenocarcinoma A549 cells; Selenite; Selenomethionine; Two dimensional NMR

Indexed keywords

ANTINEOPLASTIC AGENT; CARBON 13; EBSELEN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; METHYLSELENINIC ACID; SELENITE; SELENIUM DERIVATIVE; SELENOMETHIONINE;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CLINICAL TRIAL; CONFERENCE PAPER; DOWN REGULATION; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; LUNG CANCER; MASS SPECTROMETRY; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TRANSCRIPTOMICS;

ANIMALS; ANTICARCINOGENIC AGENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; NEOPLASMS; PROTEOMICS; SELENIUM; TRANSCRIPTION, GENETIC;

EID: 33845423112     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.1080/03602530600959599     Document Type: Conference Paper

References (44)

1. Aledo, J. C., Gomez-Fabre, P. M., Olalla, L., Marquez, J. (2000). Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mammalian Genome 11(12):1107-1110.
2. Arner, E. S., Holmgren, J., A. (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267(20):6102-6109.
3. Becker, K., Gromer, S., Schirmer, R. H., Mueller, S. (2000). Thioredoxin reductase as a pathophysiological factor and drug target. Eur. J. Biochem. 267(20):6118-6125.
4. Calvo, A., Xiao, N. Q., Kang, J., Best, C. I. M., Leiva, J., Emmert-Buck, M. R., Jorcyk, C., Green, J. E. (2002). Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res. 62(18):5325-5335.
5. Carling, D., Zammit, V. A., Hardie, D. G. (1987). A common bicyclic protein-kinase cascade inactivates the regulatory enzymes of fatty-acid and cholesterol-biosynthesis. FEBS Lett. 223(2):217-222.
6. Clark, L. C., Dalkin, B., Krongrad, A., Combs, G. E. Jr., Turnbull, B. W., Slate, E. H., Witherington, R., Herlong, J. H., Janosko, E., Carpenter, D., Borosso, C., Falk, S., Rounder, J. (1998). Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br. J. Urol. 81(5):730-734.
7. Fan, T., Bandura, I., Higashi, R., Lane, A. (2006). Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells. Metabolomics J. 1(4):325-339
8. Fan, T. W.-M. (1996). Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Progress in Nuclear Magnetic Resonance Spectroscopy 28:161-219.
9. Fan, T. W.-M. (1996). Recent Advancement in Profiling Plant Metabolites by Multi-Nuclear and Multi-dimensional NMR. Rockville, MD: American Society of Plant Physiologists.
10. Fan, T. W.-M., Lane, A. N., Higashi, R. M. (2004). The promise of metabolomics in cancer molecular therapeutics. Current Opinion in Molecular Therapeutics 6(6):584-592.
11. Fan, T. W. M., Colmer, T. D., Lane, A. N., Higashi, R. M. (1993). Determination of metabolites by proton NMR and GC analysis for organic osmolytes in crude tissue extracts. Anal. Biochem. 214(1):260-271.
12. Fan, T. W. M. Lane, A. N., Higashi, R. M. (2004). An electrophoretic profiling method for thiol-rich phytochelatins and metallothioneins. Phytochem. Anal. 15(3):175-183.
13. Fan, T. W. M., Lane, A. N., Pedler, J., Crowley, D., Higashi, R. M. (1997). Comprehensive analysis of organic ligands in whole root exudates using nuclear magnetic resonance and gas chromatography-mass spectrometry. Anal. Biochem. 251(1):57-68.
14. Farber, S. A., Slack, B. E., Blusztajn, J. K. (2000). Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease. FASEB J. 14(14):2198-2206.
15. Ganther, H. E. (1999). Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis (Oxford) 20(9):1657-1666.
16. Gradwell, M. J., Fan, T. W.-M., Lane, A. N. (1998). Analysis of phosphorylated metabolites in crayfish extracts by two-dimensional 1H-31P NMR heteronuclear total correlation spectroscopy (hetero TOCSY). Anal. Biochem. 263(2):139-149.
17. Hirai, M. Y., Yano, M., Goodenowe, D. B., Kanaya, S., Kimura, T., Awazuhara, M., Arita, M., Fujiwara, T., Saito, K. (2004). Integration of transcriptomics and metabolomics for understanding of global responses to nutritional stresses in Arabidopsis thaliana. PNAS 101(27):10205-10210.
18. Huang, L. E., Arany, Z., Livingston, D. M., Bunn, H. F. (1996). Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271(50):32253-32259.
19. Ip, C., Thompson, H. J., Zhu, Z., Ganther, H. E. (2000). In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 60(11):2882-2886.
20. Jacob, C., Maret, W., Vallee, B. L. (1998). Ebselen, a selenium-containing redox drug, releases zinc from metallothionein. Biochem. Biophys. Res. Comm. 248:569-573.
21. Larsen, E. H., Hansen, M., Fan, T., Vahl, M. (2001). Speciation of selenoamino acids, selenonium ions and inorganic selenium by ion exchange HPLC with mass spectrometric detection and its application to yeast and algae. J. Anal. At. Spectrom. 16(12):1403-1408.
22. Lemly, A. D. (2002). Symptoms and implications of selenium toxicity in fish: The Belews Lake case example. Aquatic Toxicol. (Amsterdam) 57(1-2):39-49.
23. Lindon, J. C., Nicholson, J. K., Everett, J. R. (1999). NMR spectroscopy of biofluids. In: Annual Reports on NMR Spectroscopy, Vol 38. San Diego: Academic Press Inc., pp. 1-88.
24. Lindsley, J. E., Rutter, J. (2004). Nutrient sensing and metabolic decisions. Comp. Biochem. Physiol. B, Biochem. Mol. Biol. 139(4): 543-559.
25. Lutz, N. W. (2005). From metabolic to metabolomic NMR spectroscopy of apoptotic cells. Metabolomics: 1-18.
26. McMurry, J. E., Begley, T. P. (2005). The Organic Chemistry of Biological Pathways. Greenwood Village, CO: Roberts and Company Publishers.
27. Merrill, G. F., Dowell, P., Pearson, G. D. (1999). The human p53 negative regulatory domain mediates inhibition of reporter gene transactivation in yeast lacking thioredoxin reductase. Cancer Res. 59(13):3175-3179.
28. Murray, R. K., Granner, D. K., Mayes, P. A., Rodwell, V. W. (2003). Harper's Illustrated Biochemistry. New York: McGraw-Hill Companies, Inc.
29. Mustacich, D., Powis, G. (2000). Thioredoxin reductase. Biochem. J. 346(1):1-8.
30. Rujoi, M., Jin, J., Borchman, D., Tang, D., Yappert, M. C. (2003). Isolation and lipid characterization of cholesterol-enriched fractions in cortical and nuclear human lens fibers. Invest. Ophthalmol. Visual Sci. 44(4):1634-42.
31. Ruzsanyi, V., Baumbach, J. I., Sielemann, S., Litterst, P., Westhoff, M., Freitag, L. (2005). Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers. J. Chromatog. A 1084(1-2):145-151.
32. Saghatelian, A., Trauger, S. A., Want, E. J., Hawkins, E. G., Siuzdak, G., Cravatt, B. E. (2004). Assignment of endogenous substrates to enzymes by global metabolite profiling. Biochemistry 43(45):14332-14339.
33. Sanjuan, M. A., Jones, D. R., Izquierdo, M., Merida, I. (2001). Role of diacylglycerol kinase {alpha} in the attenuation of receptor signaling. J. Cell Biol. 153(1):207-220.
34. Sasada, T., Nakamura, H., Ueda, S., Sato, N., Kitaoka, Y., Gon, Y., Takabayashi, A., Spyrou, G., Holmgren, A., Yodoi, J. (1999). Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II). Free Radical Biol. Med. 27(5-6):504-514.
35. Schenk, H., Klein, M., Erdbrugger, W., Droge, W., Schulze-Osthoff, K. (1994). Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-{kappa}B and AP-1. PNAS 91(5):1672-1676.
36. Schrauzer, G. N. (2002). Selenomethionine: A review of its nutritional significance, metabolism and toxicity (Reprinted from Vol.130, pp. 1653, 2000). J. Nutr. 132(12):1653-1656.
37. Skorupa, J. P., Ohlendorf, H. M. (1991). Contaminants in Drainage Water and Avian Risk Thresholds. Norwell, MA: Kluwer Academic Publishers, p. 345.
38. Stadtman, T. C. (2000). Selenium biochemistry - Mammalian selenoenzymes. In: Reactive Oxygen Species: From Radiation to Molecular Biology. New York: New York Acad. Sci. 899:399-402.
39. Tanaka, T., Kohno, H., Murakami, M., Kagami, S., El-Bayoumy, K. (2000). Suppressing effects of dietary supplementation of the organoselenium 1,4-phenylenebis(methylene)selenocyanate and the Citrus antioxidant auraptene on lung metastasis of melanoma cells in mice. Cancer Res. 60(14):3713-3716.
40. Vasta, V., Meacci, E., Farnararo, M., Bruni, P. (1995). Glutamine transport and enzymatic-activities involved in glutaminolysis in human platelets. Biochim. Biophys. Acta - General Subjects 1243(1):43-48.
41. Yan, L., Yee, J. A., Li, D. H., McGuire, M. H., Graef, G. L. (1999). Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice. Anticancer Res. 19(2A):1337-1342.
42. Yan, L., Yee, J. A., McGuire, M. H., Graef, G. L. (1997). Effect of dietary supplementation of selenite on pulmonary metastasis of melanoma cells in mice. Nutr. Cancer - An International Journal 28(2):165-169.
43. Yappert, M. C., Rujoi, M., Borchman, D., Vorobyov, I., Estrada, R. (2003). Glycero- versus sphingo-phospholipids: correlations with human and non-human mammalian lens growth. Experimental Eye Res. 76(6):725-734.
44. Zhao, H. J., Whitfield, M. L., Xu, T., Botstein, D., Brooks, J. D. (2004). Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells. Mol. Biol. Cell 15(2):506-519.